GEOVAX LABS INC GOVX 深 滬
已收盤 11-14 16:00:00 美东时间
0.4511
-0.018
-3.82%
華盛通- 最 高0.4598
- 今 開0.4296
- 成交量 55.84万股
- 最 低 0.415
- 昨 收 0.469
- 總市值 1143.97万
- 52周最高 3.15
- 市盈率 靜 --
- 換手率 2.20%
- 52周最低 0.415
- 委 比 -96.72%
- 總股本 2535.96万
- 歷史最高 130.65
- 量 比 0.84
- 振 幅 9.55%
- 歷史最低 0.415
- 每 手 1
- 風險率 0.68%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多GeoVax outlines expedited GEO-MVA clinical trial and global partnership strategy for 2025-2026
Earnings Call Insights: GeoVax Labs (GOVX) Q3 2025 Management View David Dodd, Chairman, President & CEO, stated that "We remain confident in the continued progress and compelling outlook for our port...
11-14 11:42
Geovax Labs Q3 EPS $(0.31) Misses $(0.25) Estimate
Geovax Labs (NASDAQ:GOVX) reported quarterly losses of $(0.31) per share which missed the analyst consensus estimate of $(0.25) by 24 percent. This is a 65.93 percent increase over losses of $(0.91) per share from the
11-14 05:07
美股大行评级 | 潜在涨幅485.44%！Allarity Therapeutics获机构升目标价至9.25美元，维持"买入"评级
今日重点评级关注：Ascendiant Capital：维持Allarity Therapeutics"买入"评级，目标价从9美元升至9.25美元；JMP证券：维持Crinetics Pharmaceuticals"跑赢大市"评级，目标价从86美元升至143美元
09-29 09:15
D. Boral Capital Maintains Buy on Geovax Labs, Maintains $9 Price Target
D. Boral Capital analyst Jason Kolbert maintains Geovax Labs (NASDAQ: GOVX) with a Buy and maintains $9 price target.
09-26 19:25
Shares of vaccine companies are trading lower following a Daily Beast report suggesting that President Trump and Health and Human Services Robert F. Kennedy, Jr. will ban Covid-19 vaccines "within months." Also, a report suggested that a Covid-19 vaccine skeptic will lead the Covid-19 immunization task force.
Shares of vaccine companies are trading lower following a Daily Beast report su...
08-26 01:50
GeoVax Labs Receives Nasdaq Deficiency Letter
GeoVax Labs ( ($GOVX) ) has provided an announcement. On July 31, 2025, GeoVax ...
08-02 05:01
D. Boral Capital Maintains Buy on Geovax Labs, Maintains $9 Price Target
D. Boral Capital analyst Jason Kolbert maintains Geovax Labs (NASDAQ:GOVX) with a Buy and maintains $9 price target.
07-29 21:14
Geovax Labs Q2 EPS $(0.35) Beats $(0.36) Estimate, Sales $852.282K Beat $366.667K Estimate
Geovax Labs (NASDAQ:GOVX) reported quarterly losses of $(0.35) per share which beat the analyst consensus estimate of $(0.36) by 2.78 percent. This is a 82.41 percent increase over losses of $(1.99) per share from the
07-29 04:21
Earnings Scheduled For July 28, 2025
Companies Reporting Before The Bell • Bank of Hawaii (NYSE:BOH) is likely to re...
07-28 16:32
Earnings Preview For Geovax Labs
Geovax Labs (NASDAQ:GOVX) will release its quarterly earnings report on Monday,...
07-26 03:02
